Exclusive

Publication

Byline

DEPARTMENT OF ENERGY ISSUES RULE: ADMINISTRATIVE FALSE CLAIMS AND PROCEDURES

WASHINGTON, July 13 -- Department Of Energy has issued a rule called: Administrative False Claims and Procedures. The rule was published in the Federal Register on July 13 by Jennifer Hartzell, Alter... Read More


Nifty trades below 24,150 mark; metal shares decline

Mumbai, July 13 -- The key equity barometers traded with limited losses in the morning trade as investor sentiment turned risk-averse following the escalation of the US-Iran conflict, which heightened... Read More


obsession movie netflix: నెట్‌ఫ్లిక్స్‌ యూజర్లు అలర్ట్-ఓటీటీలోకి వచ్చేస్తున్న అబ్సెషన్-ప్రపంచాన్ని వణికించిన హారర్ మూవీ

భారతదేశం, జూలై 13 -- obsession movie netflix: వరల్డ్ బాక్సాఫీస్ ను షేక్ చేసి, ట్రేడ్ వర్గాలను సైతం ఆశ్చర్యపరిచిన సరికొత్త హారర్ డ్రామా 'అబ్సెషన్' (Obsession) ఇప్పుడు నెట్‌ఫ్లిక్స్ ఓటీటీ ప్రియులను అలరి... Read More


Bangkok pub fire leaves at least 27 died, several injuredPublished on: July 13, 2026 10:00 AM

Pakistan, July 13 -- At least 27 people lost their lives and several others were injured after a fire broke out at a pub in Thailand's capital, Bangkok, during the early hours of Monday, prompting a l... Read More


Success Story: इंटरव्यूअर ने फोन में डाउनलोड किया ऐप, फिर बरसाए सवाल; ऐसे मिला 1.4 करोड़ का पैकेज

नई दिल्ली, जुलाई 13 -- सफलता की कहानियां अक्सर हमें दूर से बहुत चमचमाती हुई नजर आती हैं। जब हम अखबारों में या सोशल मीडिया पर करोड़ों के पैकेज की खबर पढ़ते हैं, तो हमारा दिमाग बस उस भारी-भरकम नंबर पर अ... Read More


Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, July 13 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... Read More


Singapore Clinical Trial: A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants with Early Alzheimer's Disease

Singapore, July 13 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Effic... Read More


Singapore Clinical Trial: Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Singapore, July 13 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascend... Read More


Singapore Clinical Trial: A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Singapore, July 13 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant ... Read More


Singapore Clinical Trial: A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease

Singapore, July 13 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway... Read More